Shoreibah Mohamed, Anand Bhupinderjit S, Singal Ashwani K
Mohamed Shoreibah, Ashwani K Singal, Division of Gastroenterology and Hepatology, University of Alabama Birmingham, Birmingham, AL 35294-0012, United States.
World J Gastroenterol. 2014 Sep 14;20(34):11929-34. doi: 10.3748/wjg.v20.i34.11929.
Hepatitis C virus (HCV) infection and alcohol abuse are two most important causes of chronic liver disease in the United States. Alcoholic hepatitis is a unique clinical syndrome among patients with chronic and active alcohol abuse with a potential for high short-term mortality. About 20% of patients presenting with alcoholic hepatitis have concomitant HCV infection. Mortality from alcoholic hepatitis is increased in the presence of concomitant hepatitis C due to synergistic interaction between HCV and alcohol in causing hepatocellular damage. Large prospective randomized studies are needed to develop guidelines on the use of corticosteroids among patients with alcoholic hepatitis and concomitant HCV infection. The impact of antiviral therapy on mortality and outcome in the setting of alcoholic hepatitis remains a novel area for future research.
丙型肝炎病毒(HCV)感染和酒精滥用是美国慢性肝病的两个最重要原因。酒精性肝炎是慢性和重度酒精滥用患者中一种独特的临床综合征,具有较高的短期死亡率风险。约20%出现酒精性肝炎的患者同时合并HCV感染。由于HCV与酒精在导致肝细胞损伤方面存在协同作用,合并丙型肝炎时酒精性肝炎的死亡率会增加。需要开展大型前瞻性随机研究,以制定关于在酒精性肝炎合并HCV感染患者中使用皮质类固醇的指南。抗病毒治疗对酒精性肝炎患者死亡率和预后的影响仍是未来研究的一个新领域。